NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 14:00-14:07 |
Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE after Biliary Drainage: TEMP Score |
Wen-Zhe Fan | The First Affiliated Hospital, Sun Yat-Sen University, China |
2 | 14:07-14:14 |
Thermosensitive Nanogel: A Novel Embolic Agent of TACE for HCC |
Rong Ding | Yunnan Provincial Cancer Hospital, China |
3 | 14:14-14:21 |
Effect of AFP and PIVKA-II Secretion Status on Prognosis of Advanced HCC Patients Receiving TACE plus Systemic Therapies |
Jin-Feng Bai | Yunnan Provincial Cancer Hospital, China |
4 | 14:21-14:28 |
TACE Combined with Systemic Therapy for Unresectable Liver Cancer |
Ning Ai | The Fourth Hospital of Hebei Medical University, China |
5 | 14:28-14:35 |
TACE and TKIs with or without PD-1 as First-line Treatment for Unresectable HCC: A Propensity Score Matching Study |
Xue-Gang Yang | Sichuan Cancer Hospital & Institute, China |
6 | 14:35-14:42 |
MWA vs. RFA Combined with Vertebroplasty for Vertebral Metastatic Tumors: A Retrospective Cohort Study |
Fu-An Wang | Jiangsu Subei People's Hospital, China |
7 | 14:42-15:00 |
Panelists
Hai-Dong Zhu
Zhongda Hospital, Southeast University, China /
Alex Tang
Subang Jaya Medical Centre,Malaysia /
Wen-Zhe Fan
The First Affiliated Hospital, Sun Yat-Sen University, China /
Rong Ding
Yunnan Provincial Cancer Hospital, China /
Jin-Feng Bai
Yunnan Provincial Cancer Hospital, China /
Ning Ai
The Fourth Hospital of Hebei Medical University, China /
Xue-Gang Yang
Sichuan Cancer Hospital & Institute, China /
Fu-An Wang
Jiangsu Subei People's Hospital, China /
Jian-Bo Zhao
Southern Hospital of Southern Medical University, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 15:00-15:07 |
Fruquintinib Combined with Sintilimab plus TACE for Unresectable HCC: A Single-arm Phase 2 Study |
Hui Zeng | Zhejiang Provincial Cancer Hospital, China |
2 | 15:07-15:14 |
Predictive Model of Unresectable HCC Treated with TACE-HAIC Combined with TKIs and ICIs |
Li-Nan Yin | Harbin Medical Univisity Cancer Hospital, China |
3 | 15:14-15:21 |
Transformation of IR Workflow through Smart Operating Room Development: Technological Integration and Clinical Practice |
Lin Zhu | Zhongshan Hospital Affiliated with Fudan University, China |
4 | 15:21-15:28 |
Can Commonly Used Large Language Models Be Recommend Interventional Therapy to Liver Cancer Patients? |
Zhi-Hui Chang | Shengjing Hospital of China Medical University, China |
5 | 15:28-15:35 |
Association between TACE Refractoriness and Prognosis in Chinese Patients with HCC: A Retrospective Cohort Study |
Qin-Xue Sun | Ningbo Medical Center Li Huili Hospital, China |
6 | 15:35-16:00 |
Panelists
Hyun Ki Yoon
Asan Medical Center, University of Ulsan College of Medicine, Korea /
Prijo Sidipratomo
Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Indonesia /
Hui Zeng
Zhejiang Provincial Cancer Hospital, China /
Li-Nan Yin
Harbin Medical Univisity Cancer Hospital, China /
Lin Zhu
Zhongshan Hospital Affiliated with Fudan University, China /
Zhi-Hui Chang
Shengjing Hospital of China Medical University, China /
Qin-Xue Sun
Ningbo Medical Center Li Huili Hospital, China
|
NO. | Beijing Time (UTC+8) | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
1 | 16:00-16:10 |
Passing the Torch Mentoring Program: Introduction |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
2 | 16:10-16:20 |
Passing the Torch Mentoring Program: Leading Mission I |
Hang Yuan | Henan Cancer Hospital, China |
3 | 16:20-16:30 |
Passing the Torch Mentoring Program: Leading Mission II |
Bing-Jie Zheng | Henan Cancer Hospital, China |
4 | 16:30-16:40 |
Passing the Torch Mentoring Program: Leading Mission IIIa |
Hang Yuan | Henan Cancer Hospital, China |
5 | 16:40-16:50 |
Passing the Torch Mentoring Program: Leading Mission IIIb |
Shi-Jun Xu | Henan Cancer Hospital, China |
6 | 16:50-17:00 |
Passing the Torch Mentoring Program: Leading Mission IV |
Hong-Tao Hu | Henan Cancer Hospital, China |
7 | 17:00-17:10 |
Passing the Torch Mentoring Program: Leading Mission V |
Xi Li | The Fifth Affiliated Hospital of Sun Yat-sen University, China |
8 | 17:10-17:20 |
Passing the Torch Mentoring Program: Leading Mission VI |
Ho-Young Song | Asan Medical Center, University of Ulsan College of Medicine, Affiliated Cancer Hospital of Zhengzhou University, China |
9 | 17:20-18:00 |
Q & A and Panel Discussion (Overcoming Miscommunication & Shaping the Future)
Jiaywei Tsauo
Guangdong Provincial People's Hospital, China /
Bin-Yan Zhong
Zhejiang Cancer Hospital, China
|